| Autor: |
Lee, W.Y., Tam, C.S., Yan, P.Y., Lam, Y.Y., Duchatelet, S., Peat, R.A., Denjoy, I., Itoh, H., Berthet, M., Crotti, L., Ohno, S., Pedrazzini, M., Klug, D., Schwartz, P.J., Shimizu, W., Horie, M., Tregouet, D.A., Guicheney, P., Tiong, W.N., Hwang, S.S., Fong, A.Y.Y., Wee, C.C., Lai, L.Y.H., Tiong, L.L., Chang, B.C., Ong, T.K., Garg, P., Ashraffi, R., Chuah, S., Baho, H., Draz, S., Mously, F., Atta, J., Kouatly, A., Hussian, A., Abu zeid, H., Courtney, A., Hamilton-Craig, C., Strugnell, W., Slaughter, R., Luis, C.R., Habibian, M., Luis, S.A., Raffel, O.C., Tung, T.H., Hsiung, M.C., Wei, J., Clements, I.P., Hodge, D.O., Scott, C.G., Chai, S.C., Liew, M., Leong, G., Peng, H., Ding, J., Peng, Y., Zhang, Q., Xu, Y., Chao, X., Tian, H., Zhang, Y., Liu, Y., Tong, W.J., Liu, Y.Y., Wang, J., Zhang, Y.H., Wong, M.C.S., Yan, B., Tam, W.W.S., Wang, H.H.X., Liu, K.S.D., Liu, K.Q., Cheung, C.S.K., Tong, E.L.H., Sek, A.C.H., Cheung, N.T., Yu, C.M., Leeder, S., Griffiths, S., Poon, K.K.C., Wong, H.L., Ng, S.H., Kwok, W.T., Yeung, C.L., Yu, S.Y., Wan, Y.P., Wan, S., Underwood, M.J., Chan, P.H., Alegria-Barrero, E., Price, S., Kelleher, A., Moat, N., Mario, C.D., Franzen, O., Zhang, Y.C., Lee, A.P., Lin, Q.S., Fang, F., Wan, S., Underwood, M., Yu, C.M., Mirhoseini, S.J., Frouzannia, S.K., Mostafavi Pour Manshadi, S.M.Y., Naderi, N., Sayegh, S., Dandekar, P.G., Verma, Y. |
| Zdroj: |
European Heart Journal Supplements: Journal of the European Society of Cardiology; February 2012, Vol. 14 Issue: Supplement 1 pA3-A7, 5p |
| Abstrakt: |
Objective: This study aims to investigate physicians’ perceptions of stroke prevention management and patients’ knowledge of AF and warfarin therapy in Hong Kong. Method: Three different questionnaires modified from 4 studies from foreign countries were used to assess physicians’ perceptions of stroke prevention management, patients’ knowledge of AF and patients’ knowledge of warfarin therapy respectively. Different score systems were developed to compare the results with the foreign countries the 4 studies investigated. Physicians’ characteristics and patients’ demographics were also used in statistical analysis to find any association with the findings. Result: Sixty two physicians with different specialties, 70 warfarin users with AF and 44 warfarin users without AF were recruited in the present study. The average score of Hong Kong physicians in the knowledge of stroke prevention therapy in AF patients was lower than that of Australian family physicians (HK 2.48 vs. AUS 4.02 out of 7, p < 0.001). The mean scores of Hong Kong AF patients in the knowledge of AF were lower than that of UK (HK 1.16 vs. UK 2.24 out of 4, p < 0.001) and that of Finland (HK 2.77 vs. FIN 5.94 out of 8, p < 0.001) respectively. The mean score of Hong Kong AF patients in the knowledge of warfarin therapy was significantly lower than that of US AF patients (HK 2.39 vs. US 3.92, p < 0.001). Conclusion: Hong Kong physicians’ knowledge level of stroke prevention management was on average lower than Australian family physicians’, and Hong Kong patients’ knowledge of AF and warfarin therapy was in general poor, and poorer than that of UK and Finland patients, and US patients respectively. Interventions should be done to improve both physicians’ and patients’ knowledge in order to better utilize warfarin for AF patients. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
